BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 16360361)

  • 1. Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries.
    Palazzuoli A; Gennari L; Calabria P; Quatrini I; Vecchiato L; De Paola V; Campagna MS; Palazzuoli V; Nuti R
    Am J Cardiol; 2005 Dec; 96(12):1705-10. PubMed ID: 16360361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-type natriuretic peptide levels predict extent and severity of coronary disease in non-ST elevation coronary syndromes and normal left ventricular systolic function.
    Palazzuoli A; Maisel A; Caputo M; Fineschi M; Quatrini I; Calabrò A; Campagna MS; Franci B; Grothgar S; Pierli C; Nuti R
    Regul Pept; 2011 Feb; 167(1):129-33. PubMed ID: 21237213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function.
    Palazzuoli A; Caputo M; Fineschi M; Navarri R; Calabrò A; Cameli M; Campagna MS; Franci B; Pierli C; Nuti R; Maisel A
    Eur J Prev Cardiol; 2012 Jun; 19(3):366-73. PubMed ID: 21464097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction.
    Sadanandan S; Cannon CP; Chekuri K; Murphy SA; Dibattiste PM; Morrow DA; de Lemos JA; Braunwald E; Gibson CM
    J Am Coll Cardiol; 2004 Aug; 44(3):564-8. PubMed ID: 15358021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function.
    Palazzuoli A; Deckers J; Calabrò A; Campagna MS; Nuti R; Pastorelli M; Pasqui AL; Bruni F; Auteri A; Puccetti L
    Am J Cardiol; 2006 Nov; 98(10):1322-8. PubMed ID: 17134622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-type natriuretic peptide levels predict extent and severity of coronary artery disease in non-ST elevation acute coronary syndrome and normal left ventricular function.
    Goyal BM; Sharma SM; Walia M
    Indian Heart J; 2014; 66(2):183-7. PubMed ID: 24814112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma brain natriuretic peptide levels in coronary heart disease with preserved systolic function.
    Palazzuoli A; Calabria P; Vecchiato L; Quatrini I; Carrera A; Bruni F; Puccetti L; Pastorelli M; Pasqui AL; Auteri A
    Clin Exp Med; 2004 Sep; 4(1):44-9. PubMed ID: 15598085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: relation to coronary artery disease extension.
    Palazzuoli A; Ascione R; Gallotta M; Calabrò A; Gonnelli S; Quatrini I; Campagna MS; Franci B; Nuti R
    Int J Cardiol; 2009 Nov; 137(3):295-8. PubMed ID: 18707771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between NT-pro BNP levels and early mitral annulus velocity (E') in patients with non-ST-segment elevation acute coronary syndrome.
    Barbosa MM; Nunes Mdo C; Castro LR; Nominato LF; Alencar MC; Ribeiro AL
    Echocardiography; 2008 Apr; 25(4):353-9. PubMed ID: 18177379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence and severity of coronary artery disease and changes in B-type natriuretic peptide levels in patients with a normal systolic function.
    Kim BS; Lee HJ; Shin HS; Yoon JH; Lee HY; Kim BJ; Sung KC; Kang JH; Lee MH; Park JR
    Transl Res; 2006 Oct; 148(4):188-95. PubMed ID: 17002921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of extent of myocardial ischemia in patients with non-ST elevation acute coronary syndrome using serum B-type natriuretic peptide level.
    Choi EY; Kwon HM; Yoon YW; Kim D; Kim HS
    Yonsei Med J; 2004 Apr; 45(2):255-62. PubMed ID: 15118997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide and extent of lesion on coronary angiography in stable coronary artery disease.
    Sahinarslan A; Cengel A; Okyay K; Yazici HU; Elbey S; Cemri M; Ozdemir M; Timurkaynak T
    Coron Artery Dis; 2005 Jun; 16(4):225-9. PubMed ID: 15915074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An elevated level of BNP in plasma is related to the development of good collateral circulation in coronary artery disease.
    Xi WW; Cheng G; Lv S; Gao Q; Bu G; Zhou Y; Xu G
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):797-802. PubMed ID: 21450626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
    Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between elevated B-type Natriuretic Peptide levels with extent of coronary artery disease in patients with unstable angina and NSTEMI.
    Romel SM; Faruque M; Bari MA; Bari MS; Aditya GP; Choudhury AK; Khalequzzaman M; Alam MM; Razzaque MA; Rahman MA; Kabir MS; Ahmed KU; Alam MA
    Mymensingh Med J; 2014 Jul; 23(3):544-51. PubMed ID: 25178608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with non-sT-segment elevation myocardial infarction present with more severe systolic and diastolic dysfunction than patients with unstable angina.
    Chaowalit N; Auesethasak R; Santanakorn Y; Jakrapanichakul D; Kittipovanonth M; Chirakarnjanakorn S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S19-24. PubMed ID: 21721424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoprotegerin and B-type natriuretic peptide in non-ST elevation acute coronary syndromes: relation to coronary artery narrowing and plaques number.
    Palazzuoli A; Rizzello V; Calabrò A; Gallotta M; Martini G; Quatrini I; Campagna MS; Franci B; Nuti R
    Clin Chim Acta; 2008 May; 391(1-2):74-9. PubMed ID: 18328262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of N terminal-pro-brain (B-type) natriuretic peptide levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction.
    Giallauria F; De Lorenzo A; Pilerci F; Manakos A; Lucci R; Psaroudaki M; D'Agostino M; Del Forno D; Vigorito C
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):625-32. PubMed ID: 16874155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.